0:00:01 | well |
---|
0:00:02 | my name is jennifer occur in geneva |
---|
0:00:05 | and i met coauthor of the manuscript entitled pell appeared on comedy versus your spare |
---|
0:00:11 | down long acting intractable |
---|
0:00:13 | and subjects with schizophrenia |
---|
0:00:15 | recently treated with oral we're spare down |
---|
0:00:17 | or other or lms the context |
---|
0:00:20 | schizophrenia i faxed just over one percent of the adult population with an estimated fifty |
---|
0:00:26 | one million suffer worldwide |
---|
0:00:30 | all those symptoms can be treated of actively with in a psychotic medication |
---|
0:00:34 | for adherence to prescribe treatment is a well recognise problem |
---|
0:00:40 | for adherence is associated with clinical |
---|
0:00:43 | and functional deterioration |
---|
0:00:45 | an increased risk a relapse |
---|
0:00:47 | we have scroll addition and suicidal behaviour |
---|
0:00:52 | simplified and i psychotic medication regimens |
---|
0:00:55 | such as long acting intractable formulations |
---|
0:00:58 | may be helpful |
---|
0:00:59 | in improving adherence |
---|
0:01:02 | patients given oral once daily dosing must remember to take their medication three hundred and |
---|
0:01:08 | sixty five times a year |
---|
0:01:10 | with a long acting intractable formulation |
---|
0:01:13 | this is reduced to twenty six times yearly for biweekly dosing and twelve times yearly |
---|
0:01:19 | for monthly dosing |
---|
0:01:21 | also with marketing intractable and as the context |
---|
0:01:25 | health care providers can be certain of their patient's adherence and resources are not wasted |
---|
0:01:31 | on discarded or forgotten medication |
---|
0:01:34 | it is unclear whether certain subpopulations within the schizophrenia spectrum |
---|
0:01:39 | would be likely to benefit from these potential advantages |
---|
0:01:43 | in particular because of the similarity between the molecules |
---|
0:01:48 | one might question whether person to have failed treatment with or were spared own |
---|
0:01:53 | we show a good quote corresponds to long acting pell occurred on comedy |
---|
0:01:57 | or long acting wrist area down |
---|
0:02:00 | and this article we describe a post hoc subgroup analysis of a thirteen week randomised |
---|
0:02:06 | double one trial |
---|
0:02:08 | undertaken to address this question |
---|
0:02:11 | the original trial evaluated response to treatment with long acting intractable help her don't comedy |
---|
0:02:17 | or long acting inject upon which their down |
---|
0:02:20 | in subjects with schizophrenia who were experiencing clinically significant symptoms |
---|
0:02:26 | despite recent treatment with oral pinnits the context |
---|
0:02:30 | efficacy was measured by noting improvements in pans total score |
---|
0:02:35 | p and factor scores |
---|
0:02:37 | and c g i severity scale score a total of seven hundred and forty seven |
---|
0:02:43 | subjects from the original study were included in this subgroup analysis |
---|
0:02:48 | during the two weeks before the start of the double blind study medication two hundred |
---|
0:02:54 | and thirty three subjects had received or over spare don't |
---|
0:02:58 | four hundred and two had received another oral in a psychotic |
---|
0:03:02 | and one hundred and twelve had not received any in a psychotic medication |
---|
0:03:07 | at the end of thirteen weeks of treatment |
---|
0:03:10 | statistically significant improvements from baseline and point |
---|
0:03:14 | where seen in all f sixty measures |
---|
0:03:16 | within each group for both pell appeared on comedy |
---|
0:03:20 | under stared on long acting injection |
---|
0:03:23 | regardless of previous oral in a psychotic treatment |
---|
0:03:27 | you can see from the highlighted data |
---|
0:03:29 | that a change from base fine for all parameters appeared similar across groups |
---|
0:03:35 | their responses were statistically significant |
---|
0:03:38 | all comparisons within each group had a p-value less than or equal to zero point |
---|
0:03:44 | zero two |
---|
0:03:48 | similarly |
---|
0:03:49 | functioning improved significantly for subjects within each group |
---|
0:03:53 | for about how they are not comedy and they were spared on long acting injection |
---|
0:03:58 | personal and social performance scale |
---|
0:04:00 | or psp |
---|
0:04:02 | scores significantly improved from baselines and point among all previous treatment subgroups |
---|
0:04:08 | this speaker shows that the distribution of categorical p s p scale scores |
---|
0:04:14 | improved across all groups from baselines and point |
---|
0:04:19 | from two to sixty one percent of subjects across the subgroups analyzed experience one or |
---|
0:04:25 | more treatment immersion adverse of that |
---|
0:04:29 | common adverse events or power pair don't comedy it subjects |
---|
0:04:32 | where insomnia |
---|
0:04:34 | seven point one to twelve point six percent |
---|
0:04:37 | had a week six point three to nine percent |
---|
0:04:40 | an injection site pain |
---|
0:04:42 | three to ten point seven percent |
---|
0:04:44 | you respective of higher order we're stared on status |
---|
0:04:48 | common adverse events for all over spared on long acting injections subjects were insomnia |
---|
0:04:54 | five point sixty eight point four percent and headache |
---|
0:04:57 | five point forty nine point four percent |
---|
0:05:00 | in summary |
---|
0:05:01 | our analysis suggests that treatment with how appeared on comedy or were spared on long |
---|
0:05:06 | acting injection can be effective in patients |
---|
0:05:09 | regardless of previous oral in a psychotic treatment |
---|
0:05:13 | for patients who had previously received or over spare don't only |
---|
0:05:18 | the difference in the formulation was the mean change in the intervention |
---|
0:05:22 | as the molecules oliver remain the same or similar |
---|
0:05:27 | these data support the contribution |
---|
0:05:29 | of a long acting formulation |
---|
0:05:32 | to improving treatment response |
---|
0:05:34 | and suggest that not adherence may be a significant contributor to in an adequate efficacy |
---|
0:05:41 | oral formulations impatience with schizophrenia |
---|
0:05:45 | thank you for your interest |
---|
0:05:46 | and we hope you have found our analysis useful |
---|
0:05:49 | in the management of you are patients who are receiving in a psychotic each utterance |
---|